These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3032089)

  • 21. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
    Cermak-Mörth CM; Christian R; Unger FM
    Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO; Kennell WL; Poirier RH; Lynd FT
    Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK; Kauffman CL; Levy CS
    Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL; Nolan PE; Erlich KS; Ellis MN
    Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine.
    Yoshida T; Suzutani T; Azuma M
    Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.
    Scheck AC; Wigdahl B; De Clercq E; Rapp F
    Antimicrob Agents Chemother; 1986 Apr; 29(4):589-93. PubMed ID: 3010847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia.
    Gray JJ; Wreghitt TG; Baglin TP
    J Infect; 1989 Jul; 19(1):31-40. PubMed ID: 2550557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives.
    Baker DC; Haskell TH; Putt SR; Sloan BJ
    J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
    Freeman DJ; Sacks SL; De Clercq E; Spruance SL
    Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activities of combinations of acyclovir, vidarabine or its 5'-monophosphate, and cloned human interferons against herpes simplex virus type 2 in human and mouse fibroblast cultures.
    Crane LR; Milne DA
    Antiviral Res; 1985 Dec; 5(6):325-33. PubMed ID: 2418779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
    Reefschläger J; Wutzler P; Thiel KD; Herrmann G
    Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of antiviral activities of acyclovir in vitro and in vivo.
    Collins P
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():19-27. PubMed ID: 6313598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine.
    Allen LB; Vanderslice LK; Fingal CM; McCright FH; Harris EF; Cook PD
    Antiviral Res; 1982 Sep; 2(4):203-16. PubMed ID: 6293375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis.
    Kern ER; Richards JT; Overall JC
    Antiviral Res; 1986 Jul; 6(4):189-95. PubMed ID: 2427021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.
    Pulliam L; Panitch HS; Baringer JR; Dix RD
    Antimicrob Agents Chemother; 1986 Dec; 30(6):840-6. PubMed ID: 3028250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
    Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
    J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
    Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
    Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.